Modulation of the cyclooxygenase pathway via inhibition of nitric oxide production contributes to the anti-inflammatory activity of kaempferol

European Journal of Pharmacology

Volumn 642, Issue 1-3, 2010, Pages 169-176

  Mahat, Mahamad Yunnus A ^a   Kulkarni, Nagaraj M ^a   Vishwakarma, Santosh L ^b   Khan, Farhin R ^c   Thippeswamy, B S ^a   Hebballi, Vijay ^a   Adhyapak, Anjana A ^a   Benade, Vijay S ^a   Ashfaque, Saudagar Mohammad ^a   Tubachi, Suraj ^a   Patil, Basangouda M ^a  

^a K L E S S COLLEGE OF PHARMACY   (India)

^b L M COLLEGE OF PHARMACY   (India)

^c BHARATI VIDYAPEETH S COLLEGE OF PHARMACY   (India)

Author keywords

Cyclooxygenase; Fenugreek; Inflammation; Kaempferol; Nitric oxide; Prostaglandin

Indexed keywords

CARRAGEENAN; COLCHICINE; DEXAMETHASONE; KAEMPFEROL; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N6 (1 IMINOETHYL)LYSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; ANTIINFLAMMATORY AGENT; KAEMPFEROL DERIVATIVE; LYSINE; N(6)-(1-IMINOETHYL)LYSINE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; COULTER COUNTER; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GIEMSA STAIN; HISTOPATHOLOGY; INHIBITION KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; RESPIRATORY TRACT INFLAMMATION; SINGLE DRUG DOSE; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; EXUDATE; INFLAMMATION; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; COLCHICINE; DEXAMETHASONE; DINOPROSTONE; EXUDATES AND TRANSUDATES; INFLAMMATION; KAEMPFEROLS; LYSINE; MALE; NITRIC OXIDE; NITRITES; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 77954624041     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.05.062     Document Type: Article

References (28)

1. Bashir A., Hamburger M., Gupta P.M., Solis N.P. Flavonol glycosides from Monnina sylvatica. Phytochemistry 1991, 30:3781-3784.
2. Carlo G., Mascolo N., Izzo A.A., Capasso F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci. 1999, 65:337-353.
3. Clancy M.R., Amin A.R., Abramson S.B. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 1998, 41:1141-1151.
4. Flynn B.L. Rheumatoid arthritis and osteoarthritis: current and future therapies. Am. Pharm. 1994, 34:31-42.
5. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994, 47:55-59.
6. Gad M.Z., Khattab M. Modulation of nitric oxide synthesis in inflammation: relationship to oxygen-derived free radicals and prostaglandin synthesis. Arzneim. Forsch./Drug Res. 2000, 50:449-455.
7. Hajjar D.P., Lander H.M., Pearce S.F., Pomerantz K.B. Evidence for nitric oxide induction of cylooxygenase-1 activity by heme-independent mechanisms. FASEB J. 1994, 10:A1432.
8. Hamalainen, Nieminen R., Vuorela P., Heinonen M., Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and nitric oxide production in activated macrophages. Mediat. Inflamm. 2007, 45673.
9. Han Y., Nishibe S., Noguchi Y., Jin Z. Flavonol glycosides from the stems of Trigonella foenum-graecum. Phytochemistry 2001, 58:577-580.
10. Havsteen B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 2002, 96:67-202.
11. Ignarro L., Buga G., Wood K., Byrns R.E., Chaudhari G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:9265-9269.
12. Masferrer J.L., Seibert K. Regulation of inducible cyclooxyganse (COX-2) in inflammation. Receptor 1994, 94:25-30.
13. Masferrer J.L., Zweifel B.S., Manning P.T., Hauser S.D., Leahy K.M., Smith W.G., Isakson P.C., Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3228-3232.
14. Medeiros M.V., Binhara I.M., Moreno J.H., Zatz R., De Nucci G., Antunes E. Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenan in rats. Eur. J. Pharmacol. 1995, 285:109-111.
15. Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52:673-751.
16. Monacada S., Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 1993, 329:2002-2012.
17. Monacada S., Palmer R.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 1991, 43:109-141.
18. Moore W.M., Webber R.K., Jerome G.M., Tjoeng F.S., Misko T.P., Currie M.G. L-N-(1-Iminoethyl) lysine: a selective inhibitor of inducible nitric oxide synthase. J. Med. Chem. 1994, 37:3886-3888.
19. Radomski M.W., Palmer R.J., Monacada S. Glucocorticoids inhibit the expression of an inducible but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:10043-10047.
20. 2 release from the hypothalamus. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11543-11546.
21. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:7240-7244.
22. Salvemini D., Seibert K., Masferrer J.L., Misko T.P., Currie M.G., Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest. 1994, 93:1940-1947.
23. Salvemini D., Manning P.T., Zweifel B.S., Seibert K., Connor J., Currie M.G., Needlemen P., Masferrer J.L. Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 1995, 96:301-308.
24. Salvemini D., Settle L., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Regulation of prostaglandin production by nitric oxide: an in vivo analysis. Br. J. Pharmacol. 1995, 114:1171-1178.
25. Sedgwick A.D., Lees P. Studies of eicosanoid production in the air pouch model of synovial inflammation. Agents Actions 1986, 18:429-438.
26. Vane J.R., Mithcell J.A., Appleton I., Tomlinson A., Bishop B.D., Croxtall J., Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2046-2050.
27. Varshney I.P., Beg M.A. Study of saponins from the seeds of Trigonella foenum-graecum Linn. Indian J. Chem. 1978, 16B:1134-1136.
28. Willis A. Parallel assay of prostaglandin like activity in rat inflammatory exudates by means of cascade superfusion. J. Pharm. Pharmacol. 1969, 21:126-132.